コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 data on outcomes of people hospitalized with respiratory illness.
2 sociated with an outbreak of enterovirus-D68 respiratory illness.
3 subset of three of the seven hospitals with respiratory illness.
4 l swabs for the detection of RSV during each respiratory illness.
5 RT-PCR) after a clinical encounter for acute respiratory illness.
6 samples collected from patients with febrile respiratory illness.
7 4.3%-86.9%) against medically attended acute respiratory illness.
8 responsible for seasonal epidemics of acute respiratory illness.
9 the diagnosis of asthma or prior history of respiratory illness.
10 roportion of individuals who sought care for respiratory illness.
11 d monitored for 5 d for the development of a respiratory illness.
12 nery to replicate, resulting in epidemics of respiratory illness.
13 ost patients presented with an acute febrile respiratory illness.
14 ficantly contributes to hospitalizations for respiratory illness.
15 y recognized as a significant cause of adult respiratory illness.
16 T and MPO, ambient air pollutants, and acute respiratory illness.
17 n general are determinants of postdeployment respiratory illness.
18 bited each of 11 symptoms and signs of acute respiratory illness.
19 ring or after a clinical encounter for acute respiratory illness.
20 y discovered paramyxovirus that causes acute respiratory illness.
21 persons admitted to the hospital with acute respiratory illness.
22 f HRV PCR positivity to clinical symptoms of respiratory illness.
23 e East respiratory syndrome-CoV, cause acute respiratory illness.
24 infection is most frequently associated with respiratory illness.
25 f enterovirus D68 (EV-D68)-associated severe respiratory illness.
26 ter in 4 states were hospitalized with acute respiratory illness.
27 ted with isolated cases or small clusters of respiratory illness.
28 in the United States associated with severe respiratory illness.
29 ncommon human pathogen, associated with mild respiratory illness.
30 tter understand the role of EV-D68 in severe respiratory illness.
31 one symptom that was consistent with a viral respiratory illness.
32 eumovirus (HMPV) is a leading cause of acute respiratory illness.
33 breathing problems, tiring easily, and acute respiratory illnesses.
34 tendees had multiple viruses detected during respiratory illnesses.
35 bidity and mortality from cardiovascular and respiratory illnesses.
36 cold symptoms and again during self-reported respiratory illnesses.
37 ease, and more than 1.1 million cases of all respiratory illnesses.
38 te differences in the cause and prognosis of respiratory illnesses.
39 , including cardiovascular, oncological, and respiratory illnesses.
40 mens were collected from subjects with acute respiratory illnesses.
41 ssociated with emergency room visits for all respiratory illnesses.
42 as first-line treatment for various chronic respiratory illnesses.
43 collected from subjects with reported acute respiratory illnesses.
44 nificant differences in hospitalizations for respiratory illness (1.1% compared with 2.2%, respective
46 patients were more likely to report febrile respiratory illness (57% vs 11%; P< .001) and to have ha
47 ntified 26 residents and 13 staff with acute respiratory illness; 8 residents (31%) developed radiogr
49 mplicated in a widespread outbreak of severe respiratory illness across the USA in 2014 and has also
50 In 2014, EV-D68 caused widespread severe respiratory illness across the USA, disproportionately a
51 with the large outbreak of EV-D68-associated respiratory illness, although direct laboratory evidence
52 ld likely substantially reduce the burden of respiratory illness among children in rural and urban ar
56 ghts the importance of surveillance for mild respiratory illness among populations frequently exposed
57 HRV-C is increasingly associated with lower respiratory illness among populations such as children a
58 dence interval, 30.2%-89.1%) against febrile respiratory illness and 66.4% (95% CI, 14.3%-86.9%) agai
59 al secretions were sampled during periods of respiratory illness and at 1 year of age and were analyz
63 navirus (MERS-CoV) infection causes an acute respiratory illness and is associated with a high case f
64 onal pilot study to identify absences due to respiratory illness and laboratory-confirmed influenza i
66 cimens from hospitalized patients with acute respiratory illness and outpatients with influenza-like
68 , we enrolled hospitalized adults with acute respiratory illness and tested each for influenza using
69 tensive care units (PICUs) with acute severe respiratory illness and testing positive for influenza w
71 health concern, causing tens of millions of respiratory illnesses and 250,000 to 500,000 deaths worl
72 working adults with medically attended acute respiratory illnesses and compared outcomes for subjects
73 es such as vaccination could decrease severe respiratory illnesses and complications in the elderly.
74 es collected from children hospitalized with respiratory illnesses and positive for influenza by age
75 virus (CoV) HKU1 is a pathogen causing acute respiratory illnesses and so far little is known about i
76 collected from subjects with reported acute respiratory illnesses and tested by real-time reverse tr
77 specific associations with more severe viral respiratory illnesses and the risk of virus-induced exac
78 to individual differences in childhood viral respiratory illnesses and virus-induced exacerbations of
79 , five with enterovirus-D68-associated upper respiratory illness, and 16 with aseptic meningitis or e
80 nce for influenza-like illness, severe acute respiratory illness, and laboratory-confirmed influenza
81 posure is known to cause allergic reactions, respiratory illness, and may be responsible for some for
82 ngitis, gastroenteritis, encephalitis, acute respiratory illness, and neonatal sepsis-like disease.
84 pecimens [637 (89%) from patients with acute respiratory illness] and 400 cerebrospinal fluid specime
85 tiviral receipt among outpatients with acute respiratory illness (ARI) and antibiotic receipt among p
86 spitalizations associated with febrile acute respiratory illness (ARI) during a 2-year period (July 2
88 Outbreaks of human adenovirus (HAdV) acute respiratory illness (ARI) have been well documented amon
89 years of age who were hospitalized for acute respiratory illness (ARI) in 3 US counties during Octobe
90 d within a prospective cohort study of acute respiratory illness (ARI) in Andean children <3 years of
93 ors from prospective, population-based acute respiratory illness (ARI) surveillance at a large US ped
94 ons vaccinated among 192 controls with acute respiratory illness (ARI) who tested negative for influe
95 nation had 37.7% effectiveness against acute respiratory illness (ARI), 50.3% against a febrile episo
96 ousehold data to measure self-reported acute respiratory illness (ARI), before, during, and after sch
97 ccine for prevention of RSV-associated acute respiratory illness (ARI), defined by specified symptoms
102 The severity and rates of rhinovirus acute respiratory illnesses (ARIs) in adults are uncertain.
103 exacerbation of asthma and causes most acute respiratory illnesses (ARIs), which may manifest as infl
106 ginning in August, 2014, increases in severe respiratory illness associated with EV-D68 were reported
108 aining facility reported a cluster of severe respiratory illnesses associated with a rare human adeno
109 es was examined among outpatients with acute respiratory illness at 5 US sites using a test-negative
110 olated from recruits presenting with febrile respiratory illness at 8 training sites nationwide betwe
111 from children presenting with upper or lower respiratory illness at acute care visits were tested for
112 ths of age or older who presented with acute respiratory illness at ambulatory care clinics in geogra
113 of Health investigated an outbreak of lower respiratory illnesses at a hospital in Jordan; 2 fatal c
115 ith several human disease conditions such as respiratory illnesses, auto-immune disorders and hepatit
116 , Illinois, and Colorado showed increases in respiratory illness between August and September, 2014,
117 occus species and age of first febrile lower respiratory illness, both of which are known asthma risk
119 s study: (1) describes the viral etiology of respiratory illness by prospectively collecting weekly s
120 (20.0% vs. 9.9%; P = 0.02); early life lower respiratory illness caused by respiratory syncytial viru
121 etions of infants surviving various forms of respiratory illness caused by RSV or influenza viruses,
124 Pertussis is a highly contagious, acute respiratory illness caused by the bacterial pathogen Bor
128 RV-C was significantly associated with lower respiratory illness, compared with HRV-A (P = .014).
129 e of acute gastroenteritis, while in animals respiratory illness, conjunctivitis, stomatitis, and hem
130 ct of masks and respirators against clinical respiratory illness (CRI) (risk ratio [RR] = 0.59; 95% c
132 2 hospitals in southeast Michigan for acute respiratory illnesses, defined by admission diagnoses, o
133 oportion of household contacts in whom acute respiratory illness developed decreased with the size of
135 eholds (72% of the 216 households), an acute respiratory illness developed in none of the household c
137 s aged >/=50 years who sought care for acute respiratory illness during 3 influenza seasons: 2008-200
141 ult populations under surveillance for acute respiratory illness during the winters of 1999-2003.
142 (Ad14) that has caused increased severity of respiratory illnesses during globally distributed outbre
147 e-specific rates of medically attended acute respiratory illness for health plan members at the inter
148 V1 are major viral causes of acute pediatric respiratory illness for which no vaccines or suitable an
149 anthrax and identified high risks of serious respiratory illnesses for persons infected with human im
150 ct of the new adenovirus vaccines on febrile respiratory illness (FRI) and adenovirus rates and inves
152 60s in association with outbreaks of febrile respiratory illness (FRI) in military boot camps and civ
153 ary training setting, where rates of febrile respiratory illness (FRI) often reach epidemic levels.
154 Data were collected from ongoing febrile respiratory illness (FRI) surveillance and from a retros
158 infection that is associated with a range of respiratory illnesses, from common cold-like symptoms to
159 syndromes, including asymptomatic infection, respiratory illness, gastroenteritis, and meningitis.
160 ects reporting with moderate to severe acute respiratory illness had illness and virus quantitation f
162 th related coronaviruses, which cause lesser respiratory illnesses, has recently focused on the uniqu
163 wborn (PPHN), a potentially serious but rare respiratory illness, have made clinicians and patients m
164 azard ratio = 2.07, 95% CI: 1.79, 2.40), and respiratory illness (hazard ratio = 2.48, 95% CI: 2.12,
165 tributed to a modest proportion of all-cause respiratory illness hospitalization among black-African
166 tes pneumonia from other causes of childhood respiratory illness, hypoxia and increased work of breat
167 CoV illnesses were compared with other acute respiratory illnesses identified by active surveillance,
168 es from a prospective, longitudinal study of respiratory illness in 119 children who attended daycare
170 thly hospitalization and mortality rates for respiratory illness in 37 army camps, as well as the rat
175 he host cell machinery to replicate, causing respiratory illness in annual epidemics and pandemics of
177 ase cases in North America, including severe respiratory illness in children and acute flaccid myelit
178 is a causative agent of recent outbreaks of respiratory illness in children in the United States.
179 istent with anecdotal reports of a preceding respiratory illness in Guillain-Barre syndrome and has i
180 irus, nCoV, as the causative agent of severe respiratory illness in humans originating in Saudi Arabi
181 hat cause neurotoxic shellfish poisoning and respiratory illness in humans, as well as massive fish k
183 Bacillus cereus G9241 causes an anthrax-like respiratory illness in humans; however, the molecular me
184 rtunistic environmental pathogen that causes respiratory illness in immunocompromised patients, such
185 ) infection is a major cause of severe lower respiratory illness in infants and young children, but t
187 olated from a patient who died from a severe respiratory illness in June, 2012, in Jeddah, Saudi Arab
188 Adenoviruses can cause outbreaks of febrile respiratory illness in military trainees, but until 2007
189 ved association between O. cf. ovata blooms, respiratory illness in people, and detection of palytoxi
190 dle East respiratory syndrome," "coronavirus respiratory illness in Saudi Arabia," and "novel (beta)
191 f MERS-CoV infection, or someone with severe respiratory illness in the 14 days before the onset of i
194 cimens from patients in a recent outbreak of respiratory illness in the lower Hudson Valley, New York
195 D68 (EV-D68) caused a widespread outbreak of respiratory illness in the United States in 2014, predom
196 >/=9 years old with medically-attended acute respiratory illness in the US Influenza Vaccine Effectiv
197 >/=9 years old with medically-attended acute respiratory illness in the US Influenza Vaccine Effectiv
198 ignificantly associated with childhood lower respiratory illness in this population for several decad
199 causes acute, and occasionally fatal, lower respiratory illness in young infants, the elderly, and i
204 that face masks and hand hygiene may reduce respiratory illnesses in shared living settings and miti
206 age hospitalized with any sign or symptom of respiratory illness (including suspected sepsis or apnea
207 preciation of their role in more-significant respiratory illnesses, including bronchiolitis in infanc
210 human disease ranging from conjunctivitis to respiratory illnesses, including the 2009-10 A(H1N1)pdm0
213 he identification of multiple viruses during respiratory illness is increasing with advances in rapid
217 outcomes from mild conjunctivitis to severe respiratory illnesses, it is not clear where the HA of t
218 Lid swelling in the absence of recent upper respiratory illness, lacrimal gland focus, multiple orbi
219 asthma-like symptoms after early-life lower respiratory illness (LRI) caused by respiratory syncytia
220 ations for IHD- and medically attended acute respiratory illness (MAARI) (RR=1.42) were significantly
221 ed >/=6 months with medically attended acute respiratory illness (MAARI), including cough, with illne
223 Stronger surveillance for deaths due to respiratory illness may identify risk groups for targete
225 fication was common among young infants with respiratory illness, most of whom were too young to be f
226 l ddAC had a cycle delayed (FN, n = 1; acute respiratory illness, n = 1; foot blisters, n = 1; perian
227 ly, there was no identified antecedent upper respiratory illness, nor was there a preceding traumatic
233 ive, population-based surveillance for acute respiratory illness or fever among inpatient and outpati
234 dical unit of a large UK hospital with acute respiratory illness or fever higher than 37.5 degrees C
236 HBoV was not associated with the presence of respiratory illness or with specific respiratory symptom
237 est Cyanobacteria counts was associated with respiratory illness (OR = 1.37; 95% CI: 1.12, 1.67), ras
238 ples from 955 children with gastroenteritis, respiratory illness, or both, and found BuV DNA in three
239 contacts in a Jordanian hospital-associated respiratory illness outbreak in April 2012, resulting in
240 impact of PM2.5 on emergency room visits for respiratory illnesses (P = 0.001) but only at low concen
243 ologic features and cause clinically similar respiratory illness predominantly in young children.
246 bs with multiple viruses detected changed as respiratory illnesses progressed from week to week, as d
248 worsened most often with LDI, and many acute respiratory illnesses, regardless of etiology, were asso
250 We performed a retrospective analysis of respiratory illness samples from longitudinal cohorts of
251 influenza-like illness (ILI) or severe acute respiratory illness (SARI) and from asymptomatic control
252 ness (ILI) or hospitalized with severe acute respiratory illness (SARI) and tested for influenza viru
253 ublic clinics for patients with severe acute respiratory illness (SARI) at 16 regional public hospita
254 nfluenza-like illness (ILI) and severe acute respiratory illness (SARI) at 4 healthcare facilities in
255 nfluenza-like illness (ILI) and severe acute respiratory illness (SARI) had oropharyngeal and nasopha
256 uring sentinel surveillance for severe acute respiratory illness (SARI) hospitalization conducted in
257 data from 4 years of pediatric severe acute respiratory illness (SARI) sentinel surveillance in Blan
259 lness (ILI) and inpatients with severe acute respiratory illness (SARI) were enrolled at 4 sentinel f
260 d to participate in a review of severe acute respiratory illness (SARI)-associated deaths identified
264 on can lead to more severe HRV-induced lower respiratory illnesses support a causal role for allergic
266 with influenza-like illness or severe acute respiratory illness symptoms identified by surveillance
269 city babies have different patterns of viral respiratory illnesses than babies who grow up in a more
270 Human influenza is a highly contagious acute respiratory illness that is responsible for significant
271 birth occurred during the course of an acute respiratory illness that was attributed to MERS-CoV on t
272 uenza, we developed the Above Local Elevated Respiratory Illness Threshold (ALERT) algorithm, a metho
274 isting surveillance program for severe acute respiratory illness to evaluate a new multiplex real-tim
275 surveillance by routine monitoring of acute respiratory illness to obtain data on circulating strain
276 nasal washing samples collected during acute respiratory illnesses, typed into group A and B, and seq
278 accid myelitis and a sibling with only upper respiratory illness were both infected by identical ente
281 tients >/=45 years old presenting with acute respiratory illness were prospectively enrolled during t
283 who fulfilled a broad syndromic criteria of respiratory illness were tested for B. pertussis infecti
286 uenza among hospitalized patients with acute respiratory illness when influenza is circulating in a c
287 ng to the emergency department with an acute respiratory illness who met Centers for Disease Control
288 rs old and adults >/=50 years old with acute respiratory illness who participated in seasonal studies
289 seholds containing index patients with acute respiratory illness who tested positive for Yamagata- an
290 as defined as a person with an acute febrile respiratory illness who was positive for influenza A, bu
291 influenza virus recovered from patients with respiratory illness who were admitted to the major child
292 coronavirus (SARS-CoV) caused an acute human respiratory illness with high morbidity and mortality in
293 A confirmed case was defined as an acute respiratory illness with laboratory-confirmed pandemic H
294 nation histories between subjects with acute respiratory illness with positive real-time reverse tran
295 for MERS-CoV in patients with febrile and/or respiratory illness with recent travel to the Arabian Pe
296 ary shedding events are associated with mild respiratory illness with subsequent prolonged detection
297 global concern: the virus has caused severe respiratory illness, with 111 confirmed cases and 52 dea
298 9/11 and post-traumatic stress disorder and respiratory illness, with a correlation between prolonge
299 nfluenza viruses are a common cause of acute respiratory illness worldwide and generate a significant
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。